Universal Corporation Ltd] Geneva and Kiambu — Universal Corporation Ltd (UCL), a Strides Pharma Science Limited (Strides) enterprise, with support from MMV, becomes the first African manufacturer to gain WHO prequalification for their sulfadoxine-pyrimethamine + amodiaquine product. Sulfadoxine-pyrimethamine + amodiaquine (SPAQ) is a combination drug used to prevent malaria in children living in areas of seasonal malaria transmission…
Read More
About The Author
